Norbert Haider

Department of Drug and Natural Product Synthesis, University of Vienna


List of conference contributions

Poster presentations are marked with a "P", oral presentations with an "O"; the presenting author is indicated with an asterisk (*).
  1. Pyrazolo- und Isoxazolopyridazine aus Arylaminopyridazinylketonen;
    N. Haider* and G. Heinisch (O); Wissenschaftl. Tagung der Österreichischen Pharmazeutischen Gesellschaft, Graz/Austria, April 1985; Abstr.: Sci. Pharm., 53, 88 (1985).

  2. Aryl-(5-amino-4-pyridazinyl)ketones as Key Intermediates in Synthesis of Fused Pyridazines;
    N. Haider and G. Heinisch* (P); 10th International Congress of Heterocyclic Chemistry, Waterloo/Canada, Aug. 1985; Abstr.: Abstracts Volume, 10th International Congress of Heterocyclic Chemistry, 1985, P5-121.

  3. Untersuchungen zum Synthesepotential von (5-Amino-4-pyridazinyl)-arylketonen: Darstellung von Pyrimido[4,5-d]- und Pyrido[2,3-d]pyridazinen;
    N. Haider and G. Heinisch* (O); Tagung der Deutschen Pharmazeutischen Gesellschaft, Braunschweig/Germany, Oct.1985; Abstr.: Kongreßband der Jahrestagung der DPhG, 1985, PH 1.

  4. Synthese von Diaza-Analoga des Acridons, Xanthons und Thioxanthons;
    N. Haider* and G. Heinisch (P); Gemeinsame Wissenschaftl. Tagung der ÖPhG und DPhG, Innsbruck/Austria, Sept. 1986; Abstr.: Sci. Pharm., 54, 189 (1986).

  5. Preparation of Novel Diaza-Analogues of Pharmaceutically Important Tricyclic Ketones;
    W. Dostal, N. Haider, G. Heinisch*, D. Laßnigg, and G. Lötsch (O); 11th International Congress of Heterocyclic Chemistry, Heidelberg/Germany, Aug. 1987; Abstr.: Abstracts Volume, 11th International Congress of Heterocyclic Chemistry, 1987, SC 69.

  6. Neue Triazanaphthalin- und Pyridazino[4,5-e]-1,4-diazepin-derivate aus o-disubstituierten 1,2-Diazinen;
    P.Y. Boamah, N. Haider*, G. Heinisch, and J. Moshuber (O); 7. Wissenschaftl. Tagung der ÖPhG, Vienna/Austria, April 1988; Abstr.: Sci. Pharm., 56, 3 (1988).

  7. Synthetic Approaches to Pyridazino[4,5-b]quinolin-10(5H)-ones Bearing Various Alkyl Substituents at N-5;
    N. Haider*, G. Heinisch, M. Mückschitz, and I. Volf (P); 1st International Symposium on the Chemistry and Pharmacology of Pyridazines, Strasbourg/France, Sept. 1988; Abstr.: Abstracts Volume, 1st Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 1988, 20.

  8. Recent Results in the Synthesis of Pyridine-Fused Pyridazines;
    P.Y. Boamah, N. Haider, G. Heinisch*, J. Moshuber, M. Mückschitz, and I. Volf (P); 2nd Ibn Sina Symposium on Heterocyclic Chemistry, Sinai/Egypt, Nov. 1988; Abstr.: Abstracts Volume, 2nd Ibn Sina Symp. Heterocycl. Chem., 1988, 79.

  9. Zur Synthese substituierter Pyridazino[4,5-b]chinolinone;
    M. Grabenwöger, N. Haider*, G. Heinisch, and I. Volf (P); 8. Wissenschaftl. Tagung der ÖPhG, Graz/Austria, Oct. 1989; Abstr.: Sci. Pharm., 57, 178 (1989).

  10. Novel Pyridazine Analogues of o-Aminobenzophenones;
    N. Haider*, G. Heinisch, G. Kemetmüller, and J. Moshuber (P); 2nd International Symposium on the Chemistry and Pharmacology of Pyridazines, Vienna/Austria, July 1990; Abstr.: Sci. Pharm., 58, 210 (1990).

  11. Inverse Electron-Demand Diels-Alder Reactions of Pyridazino[4,5-d]pyridazines;
    N. Haider (P), 2nd International Symposium on the Chemistry and Pharmacology of Pyridazines, Vienna/Austria, July 1990; Abstr.: Sci. Pharm., 58, 211 (1990).

  12. Neue 4-Arylchinolinderivate mit Pyridazin-Teilstruktur aus Diaza-2-Aminobenzophenonen;
    N. Haider*, G. Heinisch, and J. Moshuber (O), 9. Wissenschaftl. Tagung der ÖPhG, Innsbruck/Austria, April 1991; Abstr.: Sci. Pharm., 59, 20 (1991).

  13. Novel Amino-Substituted Aryl Pyridazinyl Ketones: Potentially Useful Building Blocks for the Construction of Fused Heterocyclic Systems;
    N. Haider*, G. Heinisch, and J. Moshuber (P); 13th International Congress of Heterocyclic Chemistry, Corvallis/Oregon (USA), Aug. 1991; Abstr.: Abstracts Volume, 13th International Congress of Heterocyclic Chemistry, 1991, PO2-74.

  14. [4+2] Cycloaddition Reactions of Pyridazino[4,5-d]pyridazines and Pyrido[3,4-d]pyridazines: Synthesis of Phthalazine and Isoquinoline Derivatives;
    N. Haider (O); 13th International Congress of Heterocyclic Chemistry, Corvallis/Oregon (USA), Aug.1991; Abstr.: Abstracts Volume, 13th International Congress of Heterocyclic Chemistry, 1991, GE3-28.

  15. On the Utilisation of 3-Substituted 4-Pyridazinecarbonitriles for the Construction of c-Annelated Pyridazines;
    K. Czech, N. Haider*, G. Heinisch, and R. Wanko (P); 1st Blue Danube Symposium on Heterocyclic Chemistry, Vienna/Austria, Sept. 1991.

  16. Intramolecular [4+2] Cycloaddition Reactions of Mono- and Bicyclic Pyridazine Derivatives with Acetylenic Side Chains;
    G. Fülep, N. Haider*, and C. Loll, (P); 15th European Colloquium on Heterocyclic Chemistry, Noordwijkerhout/Netherlands, July 1992; Abstr.: Abstracts Volume, 15th European Colloquium on Heterocyclic Chemistry, 1992, 41.

  17. (3-Amino-4-pyridazinyl)phenyl Ketones as Novel 2-Aminobenzophenone Isosters: Synthesis and Conversion into Pyrido[2,3-c]pyridazines;
    N. Haider*, G. Heinisch, and J. Moshuber (P), 3rd International Symposium on the Chemistry and Pharmacology of Pyridazines, Como/Italy, Sept. 1992; Abstr.: Abstracts Volume, 3rd Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 1992, P14.

  18. Synthese anellierter Heterocyclen durch intramolekulare inverse Diels-Alder-Reaktionen von (Alkinyl-X)-substituierten Pyridazinen;
    G. Fülep, N. Haider*, and C. Loll (P), 10. Wissenschaftl. Tagung der ÖPhG, Vienna/Austria, Sept. 1992; Abstr.: Sci. Pharm., 60, 198 (1992).

  19. 2-Fluorophenyl 3-Pyridazinyl Ketone as a Versatile Precursor for Benzo-Annelated Heterocyclic Systems;
    N. Haider*, G. Heinisch, and J. Moshuber (P), 3rd Blue Danube Symposium on Heterocyclic Chemistry, Sopron/Hungary, April 1993; Abstr.: Abstracts Volume, 3rd BDSHC, 1993, PO20.

  20. Synthesis of Condensed Heterocyclic Systems from 2-Fluorophenyl 3-Pyridazinyl Ketone;
    N. Haider*, G. Heinisch, and J. Moshuber (P), 14th International Congress of Heterocyclic Chemistry, Antwerp/Belgium, Aug. 1993; Abstr.: Abstracts Volume, 14th ICHC, 1993, P1-39.

  21. Synthese und [4+2]-Cycloadditionsreaktionen von 1,4-Bis(trifluormethyl)pyrido[3,4-d]pyridazin;
    N. Haider*, K. Mereiter, and R. Wanko (P), 11. Wissenschaftl. Tagung der ÖPhG, Graz/Austria, April 1994; Abstr.: Sci. Pharm., 62, 180 (1994).

  22. Ring Transformations of Pyrido[2,3-d]pyridazine into g-Fused Quinolines via Inverse-Electron-Demand Diels-Alder Reactions;
    N. Haider* and W. Staschek (P), 4th Blue Danube Symposium on Heterocyclic Chemistry, St. Pölten/Austria, June 1994; Abstr.: Abstracts Volume, 4th BDSHC, 1994, PO-28.

  23. 1,4-Bis(trifluoromethyl)pyrido[3,4-d]pyridazine as an Azadiene: Synthesis of g-Annelated Isoquinolines;
    N. Haider*, K. Mereiter, and R. Wanko (P); 16th European Colloquium on Heterocyclic Chemistry, Bled/Slovenia, Sept. 1994; Abstr.: Abstracts Volume, 16th European Colloquium on Heterocyclic Chemistry, 1994, 56 (P-38).

  24. Condensed Pyridazines as Azadienes in [4+2]-Cycloaddition Reactions;
    N. Haider (plenary lecture), 4th International Symposium on the Chemistry and Pharmacology of Pyridazine, Bled/Slovenia, Sept. 1994; Abstr.: Abstracts Volume, 4th Int. Symposium on the Chemistry and Pharmacology of Pyridazine, 1994, 7 (PL-5).

  25. Formation of Pyridocarbazoles in Inverse-Electron-Demand Diels-Alder Reactions of a Pyrido[3,4-d]pyridazine Azadiene;
    N. Haider*, K. Mereiter, and R. Wanko (P), 5th Blue Danube Symposium on Heterocyclic Chemistry, Casta-Papiernicka/Slovak Republic, June 1995; Abstr.: Proceedings of the 5th BDSHC, 1995, 88 (PO-24).

  26. Synthese 4-substituierter Cycloalka[g]phthalazin-1(2H)-one;
    N. Haider (P), 12. Wissenschaftl. Tagung der ÖPhG, Innsbruck/Austria, October 1995; Abstr.: Sci. Pharm., 63, 292 (1995).

  27. Versuche zum Aufbau von 3-Azaellipticin-Derivaten aus Dimethylcarbazol-2,3-dicarboxylaten;
    N. Haider and R. Wanko* (O), 12. Wissenschaftl. Tagung der ÖPhG, Innsbruck/Austria, October 1995; Abstr.: Sci. Pharm., 63, 293 (1995).

  28. Synthesis of Heterocycle-Annelated Naphthyridones with a Bridgehead Nitrogen Atom; A. Nemazany und N. Haider (P), Electronic Conference on Heterocyclic Chemistry (ECHET96), Eds. H. S. Rzepa, J. Snyder (CD-ROM), Royal Society of Chemistry publications, 1996. See also http://www.ch.ic.ac.uk/ectoc/echet96/

  29. Selected Pathways to c- and d-Fused Pyridazines;
    N. Haider* and G. Heinisch (invited lecture), 5th International Symposium on the Chemistry and Pharmacology of Pyridazines, Sopron, Hungary, Oct. 1996; Abstr.: Abstract volume of the 5th Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 1996, 21 (IL-11).

  30. Convenient Synthesis of Aminonaphthyridones;
    A. Nemazany and N. Haider* (P), 17th European Colloquium on Heterocyclic Chemistry, Regensburg, Germany, Oct. 1996; Abstr.: Abstract volume of the 17th European Colloquium on Heterocyclic Chemistry, 1996, 60 (SH 49).

  31. Ein einfacher Zugang zu g-anellierten Phthalazin-1,4(2H,3H)-dionen;
    N Haider*, E. Mavrokordatou, and A. Steinwender (P), 13. Wissenschaftl. Tagung der ÖPhG, Vienna/Austria, April 1997; Abstr.: Sci. Pharm., 65, suppl. 1, S 88 (1997).

  32. Tri- and Tetracyclic Fused Pyridazines as Potential Antineoplastic Agents;
    S. Floriani, N. Haider*, F. Khadami, and R. Wanko, (P), 7th Blue Danube Symposium on Heterocyclic Chemistry, Eger, Hungary, June 1998; Abstr.: Abstract volume of the 7th BDSHC, 1998, PO-43.

  33. Synthese neuer Pyridazino[4,5-b]carbazole als potentielle Antitumor-Wirkstoffe;
    N. Haider*, R. Jbara, and F. Khadami, (P), 14th Scientific Meeting of the Austrian Pharmaceutical Society, Graz/Austria, June 1998; Abstr.: Sci. Pharm., 66, Suppl. 1, S 49 (1998).

  34. Diels-Alder Reaction of Pyrano[3,4-b]indolones with Electron-Poor Pyridazinones: a New Pathway to Carbazole-Fused Pyridazines;
    N. Haider*, J. Käferböck, and P. Mátyus (P), Article 023, "Electronic Conference on Heterocyclic Chemistry '98", H. S. Rzepa and C. O. Kappe, (Eds), Imperial College Press, 1998, ISBN 981-02-3594-1.

  35. Pyridazinones as Electron-Deficient Dienophiles: Construction of Pyridazino[4,5-b]carbazoles;
    N. Haider*, Á. Hargitai, J. Käferböck, and P. Mátyus (P), 18th European Colloquium on Heterocyclic Chemistry, Rouen, France, Oct. 1998; Abstr.: Abstract volume of the 18th European Colloquium on Heterocyclic Chemistry, 1998, A-121.

  36. Synthesis of 3-Azaolivacine;
    N. Haider* and E. Sotelo (P), 6th International Symposium on the Chemistry and Pharmacology of Pyridazines, Clearwater Beach, Florida, USA, Nov. 1998; Abstr.: Abstract volume of the 6th Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 1998, 25 (PO-7).

  37. Pirazolo[3,4-d]piridazinok elöállítása 1,3-dipoláris cikloaddícióval;
    G. Krajsovszky*, A. Gaál, N. Haider, and P. Mátyus (P), Chemists' Conference (Organic and Drug Chemistry) of the Hungarian Chemical Association, Eger, Hungary, June 1999.

  38. Pyridazine Analogs of Pyridocarbazole Alkaloids: 3-Azaolivacine and 3-Azaellipticine;
    N. Haider*, A. Hargitai, J. Käferböck, P. Mátyus, and E. Sotelo (O), 17th International Congress of Heterocyclic Chemistry, Vienna, Austria, August 1999; Abstr.: Abstract volume of the 17th ICHC, 1999, OP-50.

  39. N-Substituierte Carbazol-2,3-dicarboximide als potentielle Antineoplastica;
    N. Haider*, R. Jbara, and U. Traar, (P), 15th Scientific Meeting of the Austrian Pharmaceutical Society, Innsbruck/Austria, Oct. 1999; Abstr.: Sci. Pharm., 67, suppl. 1, S 72 (1999).

  40. Pyridazine-Fused Carbazoles: Synthesis, Reactivity, and Antitumor Activity;
    N. Haider (plenary lecture), 7th International Symposium on the Chemistry and Pharmacology of Pyridazines, Santiago de Compostela, Spain, Sept. 2000; Abstr.: Abstract volume of the 7th International Symposium on the Chemistry and Pharmacology of Pyridazines, 2000.

  41. Convenient Synthesis of New 3-Aminocarbazole and Pyrimido[5,4-b]carbazole Derivatives;
    E. Fidesser, N. Haider*, and R. Jbara, (P), 8th Blue Danube Symposium on Heterocyclic Chemistry, Bled, Sloveniy, Sept. 2000; Abstr.: Abstract volume of the 8th BDSHC, 2000, PO-23.

  42. Synthesis of Novel Pentacyclic Imides with Antitumor Activity;
    N. Haider and J. Käferböck*, (P), 16th Scientific Meeting of the Austrian Pharmaceutical Society, Vienna/Austria, Sept. 2001; Abstr.: Sci. Pharm., 69, suppl. 1, S 50 (2001).
     
  43. Azacarbolines of the Pyridazino[4,5-b]indole Type";
    A. R. A. H. Farghaly and N. Haider* (main lecture), 8th International Symposium on the Chemistry and Pharmacology of Pyridazines, Ferrara, Italy, Oct. 2002; Abstr.: Abstract volume of the 8th Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 2002, ML-5.

  44. Pentacyclische Imide: Synthese und in-vitro Antitumor-Aktivität;
    N. Haider* and J. Käferböck, (P), 17th Scientific Meeting of the Austrian Pharmaceutical Society, Graz/Austria, April 2003; Abstr.: Sci. Pharm., 71, suppl. 1, S 35 (2003).

  45. Intramolecular [4+2] Cycloaddition Reactions of Indolylalkylpyridazines: Synthesis of Annulated Carbazoles;
    N. Haider* and J. Käferböck, (P), 10th Blue Danube Symposium on Heterocyclic Chemistry, Vienna, Austria, Sept. 2003; Abstr.: Abstract volume of the 10th BDSHC, 2003, PO-70.

  46. A Simple and Efficient Access to Pyridazine Analogs of the Indolizine and Quinolizine Ring Systems;
    N. Haider*, J. Käferböck, and S. Kiebacher, (P), 9th International Symposium on the Chemistry and Pharmacology of Pyridazines, Antwerp, Belgium, July 2004; Abstr.: Abstract volume of the 9th Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 2004, PO-6.

  47. Cycloaddition Routes to Condensed Carbazoles;
    N. Haider (plenary lecture), 21st European Colloquium on Heterocyclic Chemistry, Sopron, Hungary, September 2004; Abstr.: Abstract volume of the 21st European Colloquium on Heterocyclic Chemistry, 2004, TI-03, p. 24.

  48. Synthesis and in-vitro Antitumor Activity of 1-[(Indol-1-yl)prop-1-yn-1-yl]phthalazines and Related Compounds;
    N. Haider,* T. Kabicher, J. Käferböck, and A. Plenk (P), Joint Meeting on Medicinal Chemistry, Vienna, Austria, June 2005; Abstr.: Sci. Pharm., 73, suppl. 1, S 209 (2005).

  49. Pyridazine-Fused Carbazoles and Indoles;
    N. Haider (invited lecture), 10th International Symposium on the Chemistry and Pharmacology of Pyridazines, Strasbourg, France, June 2006; Abstract: Abstract volume of the 10th Int. Symposium on the Chemistry and Pharmacology of Pyridazines, 2006, 26.

  50. Structural Modifications in the 3-Azaolivacine Series;
    M. Emich, N. Haider,* E. Kallinger, M. Scheidleder, and S. Schimpl (P), 12th Blue Danube Symposium on Heterocyclic Chemistry, Tihány, Hungary, June 2007; Abstr.: Abstract volume of the 12th BDSHC, 2007, PO-29.
     
  51. Concise Synthesis of A-Ring Modified Analogs of the Antitumor Alkaloid Luotonin A;
    N. Haider and S. Parth (P), 13th Blue Danube Symposium on Heterocyclic Chemistry, Bled, Slovenia, September 2009; Abstr.: Abstract volume of the 13th BDSHC, 2009, PO-28.
     
  52. A Novel Thiophene Analogue of the Alkaloid Luotonin A;
    N. Haider (P), 24th European Colloquium on Heterocyclic Chemistry, Vienna, Austria, August 2010; Abstract: Abstract Volume of the 24th ECHC, 2010, PO-45.
     
  53. A Short and Efficient Synthetic Route to Novel Derivatives of Luotonin A;
    N. Haider and S. Wank (P), 7th Joint Meeting on Medicinal Chemistry, Catania, Italy, June 2011; Abstract: Abstract Volume of the 7th JMMC, 2011, p. 137.
     
  54. Synthesis and in-vitro Antitumor Activity of New b-Fused Carbazole Derivatives;
    N. Haider, B. Marian, T. Nagel, M. Tarnai, and K. Tropper (P), 4th Meeting of the Paul Ehrlich MedChem Euro-PhD Network, Hradec Králové, Czech Republic, June 2014; Abstract: Abstract Volume of the 4th Meeting of the Paul Ehrlich MedChem Euro-PhD Network.
     
  55. Structural modifications of the antitumor alkaloid Luotonin A: cycloaddition reactions as a useful tool;
    N. Haider (invited lecture), 44th Conference on Drug Synthesis and Analysis, Brno, Czech Republic, September 2015; Abstr.: Book of Abstracts, 44th Conference on Drug Synthesis and Analysis, p. 10.
     
  56. A few Remarks on the Quality of Published Carbon-NMR Data;
    N. Haider and W. Robien* (O), 24th Scientific Congress of the Austrian Pharmaceutical Society, Vienna, Austria, September 2015; Abstr.: Program and Abstracts, 24th Scientific Congress of the Austrian Pharmaceutical Society, p. 25 (PC-1).
     
  57. Setting up a web-based molecular structure database with open-source software;
    N. Haider (invited lecture), MuTaLig COST Action WG meeting, Budapest, Hungary, November 2016; Abstr.: Abstract Volume of the MuTaLig WG meeting, PL3.
     
  58. An unexpected oxidative opening of the C-ring in Luotonin A and derivatives;
    A. Ibric, K. Dutter, B. Marian, N. Haider (P), 7th Meeting of the Paul Ehrlich MedChem Euro-PhD Network, Vienna, Austria, August 2017; Abstract: Abstract Volume of the 7th Meeting of the Paul Ehrlich MedChem Euro-PhD Network.
     
  59. En route to new anticancer agents based on the alkaloid Luotonin A;
    N. Haider (plenary lecture), 46th EuroCongress on Drug Synthesis and Analysis (Conference on the 65th Anniversary of the Faculty of Pharmacy, Comenius University), Bratislava, Slovakia, September 2017; Abstract: CFPH2017 Book of Abstracts, PL-8.

     


N. Haider, 2017-09-11